Sorafenib Tosylate*
-
API Product :
Sorafenib Tosylate*
-
CEP :
-
-
WCC :
?
-
Therapeutic Use :
Antineoplastics
-
Originator :
Bayer and Onyx Pharmaceuticals
-
CAS No. :
284461-73-0
-
Trade Name. :
NEXAVAR
-
Molecular Weight :
464.825 g/mol
-
Molecular Formula :
C21H16ClF3N4O3
Application
Sorafenib is a cancer medication that interferes with the growth and spread of cancer cells in the body. Sorafenib is used to treat liver cancer, thyroid cancer, or a type of kidney cancer called advanced renal cell carcinoma
General Description
Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar),[1] is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.